Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 09-1994 | 06-1994 | 03-1994 | 12-1993 | |
| Operating Expenses | 0 | 3,680 | 3,620 | 3,910 | 0 |
| Operating Income | N/A | -3,680 | -3,620 | -3,910 | N/A |
| Pre-tax Income | 0 | -3,680 | -3,620 | -3,910 | 0 |
| Net Income Continuous | N/A | -3,680 | -3,620 | -3,910 | N/A |
| Net Income | $N/A | $-3,680 | $-3,620 | $-3,910 | $N/A |
| EBITDA(a) | $N/A | $-3,680 | $-3,620 | $-3,910 | $N/A |